Therefore, we postulated that paracetamol can decrease the synthesis of leukotrienes through the downregulation of the expression of the alox12 gene, which may explain the safety of paracetamol use among COVID-19 patients [31]. The gene discussed is ALOX12; the disease is COVID-19.